In a follow-up on Genentech’s flu drug, Xofluza, the company announced that the U.S. Food and Drug Administration (FDA) has approved a supplemental New Drug Application (sNDA) for Xofluza™ (baloxavir...

Only a few cases of the newly discovered Bourbon virus have been reported, and two of them ended in death, partly because no specific treatments are available for the tick-borne illness. Now, researchers...

As co-leaders of an international collaboration, scientists at Scripps Research have discovered that tethering four antibodies together may be an effective strategy for neutralizing all types of influenza...

The U.S. Food and Drug Administration (FDA) today approved Xofluza (baloxavir marboxil) for the treatment of acute uncomplicated influenza (flu) in patients 12 years of age and older who have been symptomatic...

A new study published by researchers from the University of Illinois at Chicago suggests that the drug oseltamivir — commonly known as Tamiflu — does not cause an increased risk of suicide...

By

On December 19, the U.S. Food and Drug Administration approved Rapivab (peramivir) to treat influenza infection in adults. Influenza, commonly known as the flu, is a contagious respiratory illness caused...

By

An analysis of phase 2 and phase 3 clinical trials shows that a single injected dose of the neuraminidase inhibitor (NAI) peramivir is safe and effective at alleviating influenza symptoms, including fever...